Document Detail


Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
MedLine Citation:
PMID:  20620726     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The purpose of this study was to assess the prognostic value of admission and discharge mid-regional pro-adrenomedullin (sAM) levels in non-ST-elevation myocardial infarction (MI) and identify values to aid clinical decision making. N-terminal pro-B-type natriuretic peptide and GRACE (Global Registry of Acute Coronary Events) score were used as comparators. BACKGROUND: sAM is a stable precursor of adrenomedullin. METHODS: We measured plasma sAM on admission and discharge in 745 non-ST-elevation MI patients (514 men, median age 70.0 +/- 12.7 years). The primary end point was a composite of death, heart failure, hospitalization, and recurrent acute MI over mean follow-up of 760 days (range 150 to 2,837 days), with each event assessed individually as secondary end points. RESULTS: During follow-up, 120 (16.1%) patients died, and there were 65 (8.7%) hospitalizations for heart failure and 77 (10.3%) recurrent acute MIs. Both admission and discharge levels were increased (median 0.81 nmol/l [range 0.06 to 5.75 nmol/l] and 0.76 nmol/l [range 0.25 to 6.95 nmol/l], respectively) compared with established normal ranges. Multivariate adjusted Cox regression models revealed that both were associated with the primary end point (hazard ratio: 9.75 on admission and 7.54 on discharge; both p < 0.001). Admission sAM was particularly associated with early (<30 days) mortality (c-statistic = 0.90, p < 0.001), and when compared with N-terminal pro-B-type natriuretic peptide and GRACE score, it was the only independent predictor of this end point. Admission sAM >1.11 nmol/l identified those at highest risk of death (p < 0.001). Patients with above-median admission sAM may benefit from revascularization. CONCLUSIONS: sAM level is prognostic for death or heart failure. Admission levels are a strong predictor of early mortality and, when >1.11 nmol/l, complements the GRACE score to improve risk stratification.
Authors:
Onkar S Dhillon; Sohail Q Khan; Hafid K Narayan; Kelvin H Ng; Joachim Struck; Paulene A Quinn; Nils G Morgenthaler; Iain B Squire; Joan E Davies; Andreas Bergmann; Leong L Ng
Related Documents :
10088206 - An experimental study of cardiac natriuretic peptides as markers of development of cong...
10956256 - Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure.
12866806 - Atenolol improves ventricular function without changing plasma noradrenaline but decrea...
20206886 - Routinely-feasible multiple biomarkers score to predict prognosis after revascularized ...
24705556 - Measurement and interpretation of electrocardiographic qt intervals in murine hearts.
14620386 - Effects of the angiotensin ii subtype 1 receptor antagonist losartan on functional reco...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  56     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-12     Completed Date:  2010-07-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  125-33     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom. dhillonos@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenomedullin / blood*
Aged
Electrocardiography
Female
Follow-Up Studies
Heart Failure / mortality
Humans
Male
Myocardial Infarction / blood*,  physiopathology
Natriuretic Peptide, Brain / blood
Patient Admission
Patient Discharge
Peptide Fragments / blood
Prognosis
Protein Precursors / blood*
Grant Support
ID/Acronym/Agency:
FS/03/028/15486//British Heart Foundation; FS/09/040//British Heart Foundation
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/Protein Precursors; 0/pro-brain natriuretic peptide (1-76); 0/proadrenomedullin; 114471-18-0/Natriuretic Peptide, Brain; 148498-78-6/Adrenomedullin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should ...
Next Document:  Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Func...